Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8

Explore clinical trials studying Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 trial results

Not Yet Recruiting

Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial

NCT07723235

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, +21 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, Not Recruiting

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

NCT04214067

Conditions: Carcinosarcoma, Endometrial Endometrioid Adenocarcinoma, Neoplasms, +6 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Community Cancer Institute Clovis, California, United States

University Oncology Associates Clovis, California, United States

John Muir Medical Center-Concord Concord, California, United States

View all 280 locations

View Trial Details

Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8

Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 trial results

Web-based Lifestyle Program, mHealth and EMA Intervention, to Improve Weight Loss in Rural Stage I-III Postmenopausal Breast and Endometrial Cancer Survivors, HERO-C Trial

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

Related conditions